ArticleFrontiers in oncologyPublished
Multi-parameter optimization of a novel anti-TROP2 MMAE antibody-drug-conjugate for solid tumor therapy
16 of 47 authors shown in byline order.
Regional connection
Verified An author affiliation on the Europe PMC record names Merck & Co. Affiliation source
- Institution
- Merck & Co.
- County
- Montgomery County
Publication record
- Type
- Article
- Venue
- Frontiers in oncology
- Published
- Topic
- Disease research
- Subject terms
- Hydrophobicity; Monoclonal antibody; Solid Tumors; Trop2; Mmae; Avidity Tuning; Stable Linker; Antibody-drug-conjugate
- PubMed ID
- 42877637
- Added to directory
- Source checked